We have also hypothesized that lovastatin may have inhibited LFA-1/ICAM interaction, impairing fibrocyte migration, which resulted in the observed decrease in circulating fibrocytes homing to the lung in our animal model of pulmonary fibrosis. Here, ITGAL is linked to pulmonary fibrosis.